abstract |
Compounds for use in the treatment or prophylaxis of Human Immunodeficiency Virus (HIV) infection, which upon contact with an HIV particle, are capable of preventing or disrupting interaction between the gp41 and gp120 envelope proteins of the said particle in the contact region between the said proteins. |